BOC Sciences - Products
London
BOC Sciences provides various research (bio)chemicals: inhibitors, building blocks, carbohydrates, nucleosides, nucleotides, GMP Products, impurities, metabolites, APIs, natural compounds, ADCs, and chiral compounds.
| Product | Description | |
|---|---|---|
| Lovastatin-[d3] | Lovastatin-[d3] is the labelled analogue of Lovastatin, which is a fungal metabolite and an inhibitor of HMG-CoA reductase. Lovastatin is an antihypercholesterolemic agent. Group: Pharmaceutical. CAS No. 1002345-93-8. Pack Sizes: 1 mg. Product ID: BLP-011607. Molecular formula: Custom synthesis is available. Send your inquiries for more information. |  London |
| Lovastatin Impurities | Lovastatin Impurities are crucial in the biomedical industry for analyzing the purity and stability of lovastatin formulations. These impurities assist researchers in understanding drug efficacy and safety profiles, ensuring effective cholesterol-lowering treatments for cardiovascular diseases, including hyperlipidemia and coronary artery disease. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Loxapine Impurities | Loxapine Impurities are critical in the pharmaceutical analysis and development of Loxapine, an antipsychotic medication used to manage schizophrenia. By identifying and quantifying these impurities, researchers ensure the safety, efficacy, and quality of Loxapine formulations, facilitating regulatory compliance and improving therapeutic outcomes. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Loxiglumide | Loxiglumide is an orally active, potent and selective small-molecule antagonist of the cholecystokinin receptor CCKA. It stimulates calorie intake and hunger feelings in humans. It could antagonize the CCK-induced reduction of gastric emptying in rats, accelerate the intestinal transport and accelerate the gallbladder emptying in mice. It inhibits pancreatic secretion of digestive enzymes, and also blocks CCK-induced gastric secretions and emptying. Uses: Loxiglumide stimulates calorie intake and hunger feelings in humans. it inhibits pancreatic secretion of digestive enzymes. Group: Pharmaceutical. CAS No. 107097-80-3. Pack Sizes: 50 mg. Product ID: B0084-053945. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| LOXO-101 sulfate | The sulfate salt form of LOXO-101, also called Larotrectinib, which is an ATP-competitive inhibitor of tropomyosin receptor kinases. It was approved by FDA for the treatment of metastatic solid tumors. Group: Pharmaceutical. CAS No. 1223405-08-0. Pack Sizes: 100 mg. Product ID: B0084-474404. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Loxoprofen Impurities | Loxoprofen Impurities hold paramount importance in pharmaceutical analytical pursuits, especially concerning the NSAID loxoprofen. Their presence necessitates rigorous quality control, pivotal in guaranteeing the therapeutic safety and effectiveness of loxoprofen in alleviating pain and inflammation linked with musculoskeletal anomalies, thereby underpinning pharmaceutical integrity and patient welfare. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Loxoprofen Related Compound 2 (Mixture of Diastereomers) | An impurity of Loxoprofen, a non-selective nonsteroidal anti-inflammatory drug (NSAID) that has been effective in reducing atherosclerosis in mice by reducing inflammation. Group: Pharmaceutical. CAS No. 1091621-62-3. Pack Sizes: 25 mg. Product ID: B2694-472588. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Loxoprofen Ring-opening Impurity | Loxoprofen Ring-opening Impurity is a degradation product of Loxoprofen, a non-selective nonsteroidal anti-inflammatory drug (NSAID) that has been effective in reducing atherosclerosis in mice by reducing inflammation. Group: Pharmaceutical. CAS No. 1091621-61-2. Pack Sizes: 5 mg. Product ID: B2694-472587. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| L-Penicillamine | L-Penicillamine is a medication primarily used for the treatment of Wilson's disease. Group: Pharmaceutical. CAS No. 1113-41-3. Pack Sizes: 10 g. Product ID: BAT-014291. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| L-Phe(1)-Octreotide trifluoroacetate salt | L-Phe(1)-Octreotide is an impurity of Octreotide, which is a synthetic long-acting cyclic octapeptide used as a more potent inhibitor of growth hormone, glucagon, and insulin than somatostatin. Group: Pharmaceutical. Pack Sizes: 10 mg. Product ID: B1370-449818. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| L-(+)-Rhamnose Monohydrate | L(+)-Rhamnose (Rham) is a naturally-occurring deoxy sugar that is found primarily in plants and some bacteria. Unlike most natural sugars, it is found in an L configuration instead of the usual D configuration. Group: Pharmaceutical. CAS No. 10030-85-0. Pack Sizes: 1 kg. Product ID: B1999-001160. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| L-Rhamnulose | L-rhamnulose is the eminent compound, aiding in elucidating perplexing metabolic disorders and facilitating avant-garde drug development. This saccharide derivative orchestrates an array of intricate biochemical reactions used in studying afflictions such as diabetes, obesity and the enigmatic metabolic syndrome. Group: Pharmaceutical. CAS No. 14807-05-7. Pack Sizes: 100 mg. Product ID: B2705-376154. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| LRRK2-IN-1 | LRRK2-IN-1 is a benzodiazepine based derivative and is known as a selective inhibitor of the Parkinson's disease kinase LRRK2. Group: Pharmaceutical. CAS No. 1234480-84-2. Pack Sizes: 100 mg. Product ID: B1370-443603. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| LS-tetrasaccharide c | LS-tetrasaccharide c is an extraordinary biomedical compound, bestowed with the exceptional ability to impede ceramide glycosyltransferase, a vital actor implicated in the relentless march of tumor propagation and metastasis. Group: Pharmaceutical. CAS No. 64003-55-0. Pack Sizes: 5 mg. Product ID: B1370-407252. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| L-Sulforaphane | L-Sulforaphane is a compound with isothiocyanate group found in cruciferous vegetables such as broccoli, Brussels sprouts, and cabbages. It has been shown to regulate phase II detoxifying enzymes and induce cell cycle arrest or apoptosis in malignant cells in vitro and in vivo, thus can be potentially used as an antioxidant and anticancer agent. Uses: Anticarcinogenic agents. Group: Pharmaceutical. CAS No. 142825-10-3. Pack Sizes: 50 mg. Product ID: B2703-084008. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| L-Theanine | L-Theanine is a glutamine analog found in the green tea plant. It can bind to glutamate receptors and inhibit glutamate transporters, which exhibits a neuroprotective effect. It promotes self-renewal of human embryonic stem cells (hESCs). Uses: l-theanine, an amino acid found primarily in tea leaves, has been widely recognized for its potential applications in drug discovery and development. this natural compound has been widely studied for its various health benefits, including its ability to promote relaxation, reduce stress, and improve cognitive function. in recent years, scientists have begun to explore l-theanine's potential in. Group: Pharmaceutical. CAS No. 3081-61-6. Pack Sizes: 1 kg. Product ID: BAT-014319. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| L-Threoninol(Ac)-8-Octreotide trifluoroacetate salt | Threoninol(Ac)-8-Octreotide is an impurity of Octreotide, which is a synthetic long-acting cyclic octapeptide used as a more potent inhibitor of growth hormone, glucagon, and insulin than somatostatin. Group: Pharmaceutical. Pack Sizes: 10 mg. Product ID: B1370-449816. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| LTI-291 | LTI-291 is a glucocerebrosidase (Gcase) activator for the treatment of Parkinson's disease (PD). Group: Pharmaceutical. CAS No. 1919820-28-2. Pack Sizes: 10 mg. Product ID: B0084-284752. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| L-Tyrosine-diethylamide hydrochloride | L-Tyrosine-diethylamide hydrochloride. Group: Pharmaceutical. Pack Sizes: 100 mg. Product ID: BAT-014381. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Lu AE58054 | Lu AE58054 is a selective and high affinity 5-HT6 receptor antagonist as a promising treatment for cognitive disorders. Uses: 5-ht(6)r antagonist. Group: Pharmaceutical. CAS No. 467459-31-0. Pack Sizes: 5 mg. Product ID: B2693-474178. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Lu AE58054 HCl salt | Lu AE58054 hydrochloride is an in-vitro potency and selectivity, in-vivo binding affinity and effect of the 5-HT(6)R antagonist with a Ki value of 0.83 nM. Group: Pharmaceutical. CAS No. 467458-02-2. Pack Sizes: 50 mg. Product ID: B2693-462285. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Lubiprostone | Lubiprostone is a bicyclic fatty acid metabolite of Prostaglandin E1. It activates ClC-2 and CFTR chloride channels in the gastrointestinal tract, increasing intestinal fluid secretion. It is used in the management of idiopathic chronic constipation, and irritable bowel syndrome with constipation. Group: Pharmaceutical. CAS No. 136790-76-6. Pack Sizes: 100 mg. Product ID: B0084-057968. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Lubiprostone Impurities | Lubiprostone Impurities, integral to analytical exploration within the biomedical realm, underpin research and development endeavors aimed at drug purity and efficacy assurance. Central to quality control operations for lubiprostone, these impurities validate therapeutic safety and effectiveness in treating chronic idiopathic constipation and irritable bowel syndrome with constipation, fortifying medicinal reliability. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Lucidenic acid A | Lucidenic acid A, a naturally occurring compound found in Ganoderma lucidum fruiting bodies, displays immense therapeutic potential. It exhibits anti-inflammatory, anti-tumor, and anti-diabetic properties as evidenced by various studies. Additionally, it significantly impacts physiological parameters such as blood pressure, cholesterol, and blood sugar. The multifaceted activities of Lucidenic acid A render it an ideal candidate for treating chronic inflammatory diseases, diabetes, and cancer. Group: Pharmaceutical. CAS No. 95311-94-7. Pack Sizes: 20 mg. Product ID: B0005-465653. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Lucidenic acid B | Lucidenic acid B, an organic compound hailing from Ganoderma lucidum, is praised for its multifaceted biomedical properties. From combating neoplasms to alleviating inflammations, this natural triterpenoid holds great promise in treating debilitating conditions such as breast and prostate cancers and an array of inflammatory disorders. Group: Pharmaceutical. CAS No. 95311-95-8. Pack Sizes: 10 mg. Product ID: B0005-465654. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Lucidenic acid C | Lucidenic acid C, an organic compound derived from the fungus Ganoderma lucidum, exhibits multifaceted pharmacological actions such as antioxidant, anti-inflammatory, immunomodulatory, and anticancer properties. Novel studies have elucidated that this naturally occurring triterpene exhibits profound inhibition of malignancy development and metastasis in cancer cells. The promising therapeutic potential of lucidenic acid C extends beyond oncology, offering a plethora of therapeutic applications in diverse pathological conditions. Group: Pharmaceutical. CAS No. 95311-96-9. Pack Sizes: 10 mg. Product ID: B0005-465650. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Lucidenic acid D | Lucidenic acid D, a triterpenoid compound, is extracted from Ganoderma lucidum and is reported to be endowed with multifarious biological activities, such as anti-cancer, anti-inflammatory, and antioxidant properties. With its remarkable potential to stimulate apoptosis in cancer cells, lucidenic acid D stands out as an effective therapeutic candidate for combating cancer and other ailments. Group: Pharmaceutical. CAS No. 98665-16-8. Pack Sizes: 10 mg. Product ID: NP7070. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Lucidenic acid E | Lucidenic acid E, a triterpenoid derived from Ganoderma lucidum, exhibits potent anti-inflammatory, anti-tumor and anti-diabetic activities. Notably, it has demonstrated the ability to impede in vitro cancer cell growth, indicating its potential therapeutic value. Its hepatoprotective and antioxidant effects further increase the promise of lucidenic acid E in the treatment of liver ailments. Such multifaceted properties of this natural compound highlight its potential in the development of novel therapies. Group: Pharmaceutical. CAS No. 98665-17-9. Pack Sizes: 5 mg. Product ID: B0005-465651. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Lucidenic acid LM1 | Lucidenic acid LM1, a triterpenoid compound, is obtained from medicinal fungi that are fit for consumption. Numerous biological activities have been ascertained to be associated with this compound such as anti-cancer, anti-inflammatory, and anti-fibrotic effects. The inhibition of human liver cancer and breast cancer cells are among the effects of Lucidenic acid LM1, which suggests its potential candidacy for the development of new anti-cancer drugs. Group: Pharmaceutical. CAS No. 364622-33-3. Pack Sizes: 10 mg. Product ID: B0005-465649. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Lucidin | Lucidin is a natural component of Rubia tinctorum L. It exhibits antibacterial activity. Group: Pharmaceutical. CAS No. 478-08-0. Pack Sizes: 100 mg. Product ID: B2703-119010. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Lucyoside B | Lucyoside B is a triterpenoid compound found in the herbs of Luffa cylindrica ROEM. Group: Pharmaceutical. CAS No. 91174-19-5. Pack Sizes: 5 mg. Product ID: B0005-053511. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Lufenuron | Lufenuron is a benzoylurea pesticide which inhibits the production of chitin in larval fleas. Group: Pharmaceutical. CAS No. 103055-07-8. Pack Sizes: 1 g. Product ID: BBF-05878. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Lufenuron Impurities | Lufenuron Impurities, identified as trace elements during pharmaceutical synthesis, play a crucial role in quality control for antifungal and antiparasitic medications, particularly in combating flea infestations. These impurities provide significant insight into drug safety and efficacy, ensuring Lufenuron's optimal performance while enhancing the development of safer therapeutic alternatives. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Luliconazole Impurities | Luliconazole Impurities are crucial analytical standards in the biomedical industry, predominantly utilized in the quality control and development of antifungal medications like luliconazole. These impurities facilitate the identification and quantification of trace components, ensuring drug safety and efficacy, particularly in treating dermatophytic infections such as athlete's foot and jock itch. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Lumacaftor | Lumacaftor is the second investigational oral candidate compound for the treatment of cystic fibrosis (CF). Lumacaftor may act to restore the function of the cystic fibrosis transmembrane conductance regulator (CFTR) protein, the defective cell membrane protein responsible for the progression of CF. Lumacaftor defects in the CFTR protein affect the transport of chloride and other ions across cells, and lead to the accumulation of thick, sticky mucus in the lungs of patients with CF. This mucus fosters chronic infection and inflammation, and results in irreversible lung damage. Group: Pharmaceutical. CAS No. 936727-05-8. Pack Sizes: 250 mg. Product ID: B0084-079818. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Lumasiran | Lumasiran is a siRNA product that reduces hepatic oxalate production by targeting glycolate oxidase. By silencing the gene encoding glycolate oxidase, Lumasiran depletes glycolate oxidase and thereby inhibits the synthesis of oxalate, which is the toxic metabolite that is directly associated with the clinical manifestations of Primary hyperoxaluria type 1 (PH1). Group: Pharmaceutical. CAS No. 1834610-13-7. Pack Sizes: 5 mg. Product ID: B1370-072716. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Lumateperone | Lumateperone, also known as ITI-722 or ITI-007, is a highly potent 5HT2A antagonist for the treatment of sleep maintenance insomnia. Preclinical data has shown that ITI-722 is not sedating and should not exhibit next day hangover effects that are commonly associated with other sleep medications. Group: Pharmaceutical. CAS No. 313368-91-1. Pack Sizes: 50 mg. Product ID: B2693-470913. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Lumateperone Impurities | Lumateperone Impurities, serving as fundamental reference standards, hold a crucial position in the biomedical sector. They underpin formulation and quality assurance processes for the antipsychotic Lumateperone, facilitating pharmacokinetic analyses. Their role is vital in safeguarding drug safety and effectiveness, particularly in addressing schizophrenia and bipolar disorder through meticulous contaminant identification and quantification. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Lumateperone Tosylate | The tosylate salt form of Lumateperone which is an highly effective antagonist of 5-HT2A receptor, could be used against insomnia. IC50: 0.54 nM(Ki). Uses: The tosylate salt form of lumateperone which is an highly effective antagonist of 5-ht2a receptor and could be used against insomnia. Group: Pharmaceutical. CAS No. 1187020-80-9. Pack Sizes: 200 mg. Product ID: B2693-474376. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Lumefantrine Impurities | Lumefantrine Impurities are critical components in the quality control and development of antimalarial drugs. They are primarily studied to ensure the efficacy and safety of lumefantrine, a key agent in treating malaria. Understanding these impurities aids in optimizing drug formulations for improved therapeutic outcomes against Plasmodium infections. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Luminespib | Luminespib, also known as AUY-922 (or NVP-AUY922), is a derivative of 4,5-diarylisoxazole and a third-generation heat shock protein 90 (Hsp90) inhibitor with potential antineoplastic activity. Hsp90 inhibitor AUY922 has been shown to bind with high affinity to and inhibit Hsp90, resulting in the proteasomal degradation of oncogenic client proteins. Group: Pharmaceutical. CAS No. 747412-49-3. Pack Sizes: 50 mg. Product ID: B0084-251226. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Luminol sodium salt | Luminol sodium salt is a reagent used in chemiluminescence analysis of metal cations, blood and glucococorticoids. Group: Pharmaceutical. CAS No. 20666-12-0. Pack Sizes: 100 g. Product ID: B1370-366297. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Lumiracoxib Impurities | Lumiracoxib Impurities, integral in pharmacological examinations, act as essential analytical markers, facilitating meticulous calibration and stringent evaluation of drug integrity and therapeutic efficacy in osteoarthritis and rheumatoid maladies. By aiding in degradation entity identification, they ensure the safety and effectiveness of lumiracoxib, a selective COX-2 inhibitor, in clinical applications. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Lunasin | Lunasin is a novel, cancer-preventive peptide whose efficacy against chemical carcinogens and oncogenes has been demonstrated in mammalian cells and in a skin cancer mouse model. Group: Pharmaceutical. Pack Sizes: 1 mg. Product ID: BAT-006145. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Lup-20(29)-en-28-oic acid, 3-[ D-glucopyranosyl(1?4)[ L-rhamnopyranosyl) (1?2)-L-arabinopyranosyl]oxy], (3,4)-) | Lup-20(29)-en-28-oic acid, 3-[ D-glucopyranosyl(1→4)[ L-rhamnopyranosyl) (1→2)-L-arabinopyranosyl]oxy], (3,4)-) is extracted from Pulsatilla chinensis (Bunge) Regel. Group: Pharmaceutical. CAS No. 848784-87-2. Pack Sizes: 5 mg. Product ID: B0005-465772. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Lup-20(29)-ene-3α,23-diol | Lup-20(29)-ene-3α,23-diol isolated from the barks of Glochidion macrophyllum. Uses: Anti-hiv activity. Group: Pharmaceutical. CAS No. 32451-85-7. Pack Sizes: 1 mg. Product ID: NP6606. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Lupenone | Lupenone is isolated from the roots of Pueraria thomsonii Benth. It effectively inhibited adipocyte differentiation through downregulating the related transcription factor, particularly the PPARγ gene. Group: Pharmaceutical. CAS No. 1617-70-5. Pack Sizes: 25 mg. Product ID: NP6327. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Lupeol | Lupeol is isolated from the flower of Chrysanthemum morifolium. It enhances the radiosensitivity of SMMC-7721 cells in vitro and in vivo. Uses: Anti-inflammatory agents. Group: Pharmaceutical. CAS No. 545-47-1. Pack Sizes: 250 mg. Product ID: NP7233. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Lurbinectedin | Lurbinectedin, also known as PM01183, is a synthetic tetrahydropyrrolo [4, 3, 2-de]quinolin-8(1H)-one alkaloid analogue with potential antineoplastic activity. DNA minor groove-binding agent PM01183 covalently binds to residues lying in the minor groove of DNA, which may result in delayed progression through S phase, cell cycle arrest in the G2/M phase and cell death. Group: Pharmaceutical. CAS No. 497871-47-3. Pack Sizes: 1 mg. Product ID: B2693-462566. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Lusutrombopag | Lusutrombopag is an orally bioavailable, small molecule thrombopoietin (TPO) receptor agonist. It acts selectively on the human TPO receptor and activates signal transduction pathways and thereby increases platelet levels. It was developed by Shionogi for chronic liver disease (CLD) patients with thrombocytopenia prior to elective invasive surgery. It has been listed. Uses: Lusutrombopag was used for chronic liver disease (cld) patients with thrombocytopenia prior to elective invasive surgery. Group: Pharmaceutical. CAS No. 1110766-97-6. Pack Sizes: 300 mg. Product ID: B0084-475066. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Lutein | Lutein is a xanthophyll isolated from the herbs of Tagetes erecta. It is isomeric with zeaxanthin thus has similar properties as zeaxanthin. Lutein exhibits antioxidant, antimutagenic and anti-tumor effects, and has the potential to treat macular degeneration. Lutein can be used in food additive. Lutein has antioxidant activity, which can protect skin cells well, make skin cells resist oxidation from the very beginning, stay away from the harm of free radicals, play a strong role in whitening, freckling, wrinkling, moisturizing, increasing skin elasticity, improve skin luster and smoothness, and delay skin aging. Uses: Ingredient of health care products. Group: Pharmaceutical. CAS No. 127-40-2. Pack Sizes: 25 mg. Product ID: BBF-05800. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Luteolin | Luteolin is an anti-inflammatory, antioxidant and free radical scavenger. Luteolin inhibits LPS-induced TNF-α, IL-6 and inducible nitric oxide production and blocks NF-κB and AP-1 activation. It also inhibits TNF-α-induced COX-2 expression, and phosphodiesterase with with Ki of 15.0 μM, 6.4 μM, 13.9 μM, 11.1 μM and 9.5 μM for PDE1-5 respectively. It inhibits proliferation of Lewis lung carcinoma cells in vivo. Luteolin is a natural compound found in the leaves of Dracocephalum ruyschiana L. It can be used in cosmetics material. Uses: Adcs cytotoxin. Group: Pharmaceutical. CAS No. 491-70-3. Pack Sizes: 5 g. Product ID: NP1855. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Luteolin-3-O-beta-D-glucuronide | Luteolin-3-O-beta-D-glucuronide is a flavonoid isolated from Rosmarinus officinalis. Group: Pharmaceutical. CAS No. 53527-42-7. Pack Sizes: 10 mg. Product ID: B2703-334466. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Luteolin 5-methyl ether | Luteolin 5-methyl ether, a flavone compound of natural origin with potent pharmacological effects, can be obtained from a variety of plant species. Its therapeutic potential encompasses a broad spectrum of health conditions such as cancer, cardiovascular diseases, diabetes, and neurodegenerative disorders, primarily due to its antioxidant, anti-inflammatory, and antitumor properties. The inspiring results from studies conducted in this realm suggest that Luteolin 5-methyl ether is a promising candidate for the development of novel therapeutic agents. Group: Pharmaceutical. CAS No. 58115-29-0. Pack Sizes: 1 mg. Product ID: NP2182. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Luteolin 7-O-glucoside | Cynaroside is a flavone, a flavonoid-like chemical compound. It is a 7-O-glucoside of luteolin. Group: Pharmaceutical. CAS No. 5373-11-5. Pack Sizes: 100 mg. Product ID: NP1883. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Luteolin-7-O-neohesperidoside | Luteolin-7-O-neohesperidoside is a flavone found in Veronicastrum sibiricum var. japonicum and in Teucrium gnaphalodes. Group: Pharmaceutical. CAS No. 25694-72-8. Pack Sizes: 10 mg. Product ID: B2703-003309. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Luteone | Luteone is a natural flavonoid isolated from the herbs of Erythrina variegata Linn. Group: Pharmaceutical. CAS No. 41743-56-0. Pack Sizes: 1 mg. Product ID: NP2140. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Luvangetin | Luvangetin is a coumarin isolated from the stem bark of Zanthoxylum ailanthoides. Luvangetin exhibits inhibition against superoxide anion (O2 -) generation and elastase release by human neutrophils in response to fMLP/CB. Group: Pharmaceutical. CAS No. 483-92-1. Pack Sizes: 5 mg. Product ID: NP1044. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Luxabendazole Impurities | Luxabendazole Impurities, integral to anthelmintic pharmacological research, are scrutinized for their role in enhancing treatment efficacy against helminthic afflictions. Their assessment focuses on the safety, stability, and pharmacodynamics of Luxabendazole, providing critical insights that underpin advancements in nematode infection therapies, ultimately elevating treatment paradigms. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| L-Valacyclovir Hydrochloride | Valaciclovir HCl is an antiviral drug used in the management of herpes simplex, herpes zoster, and herpes B. Group: Pharmaceutical. CAS No. 124832-27-5. Pack Sizes: 100 g. Product ID: B2693-082659. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Lvguidingan | Lvguidingan is an antiepileptic drug. Group: Pharmaceutical. CAS No. 82351-05-1. Pack Sizes: 50 mg. Product ID: B0084-284835. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| L-Vinylglycine | L-Vinylglycine is a non-proteinogenic L-alpha-amino acid and an inhibitor of aspartate aminotransferase. Group: Pharmaceutical. CAS No. 70982-53-5. Pack Sizes: 100 mg. Product ID: B0084-335459. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| LX-4211 | LX-4211 is a potent dual SGLT2/1 inhibitor; Antidiabetic agents. Uses: Sodium-glucose transporter 2 inhibitors. Group: Pharmaceutical. CAS No. 1018899-04-1. Pack Sizes: 50 mg. Product ID: B0084-463492. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Lx7101 Impurities | Lx7101 Impurities are vital in the biomedical field for assessing the purity and efficacy of Lx7101, an inhibitor targeting ocular diseases like glaucoma. These impurities help refine analytical methods, ensuring therapeutic effectiveness and safety, thereby facilitating advanced pharmaceutical research and development in ophthalmology. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| L-Xylulose | L-Xylulose, an organic sugar alcohol, finds significant utility within the dynamic biomedicine sector as a crucial carbohydrate source and an intermediary compound in the synthesis of pharmaceuticals and biochemicals. Group: Pharmaceutical. CAS No. 527-50-4. Pack Sizes: 50 mg. Product ID: B2705-122241. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| LY2109761 | LY2109761 is a novel inhibitor of TGF-β receptor type I/type II kinases (IC50 = 69 nM), displaying antitumor activity. In vivo study demonstrated that LY2109761, in combination with gemcitabine, significantly reduced the tumor burden, prolonged survival, and reduced spontaneous abdominal metastases. Group: Pharmaceutical. CAS No. 700874-71-1. Pack Sizes: 100 mg. Product ID: B2693-286403. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| LY2228820 dimesylate | LY2228820 dimesylate is the salt form of LY2228820, a tri-substituted imidazole derivative and p38α and β MAPK inhibitor. LY2228820 inhibits tumor growth in various cancer models. Group: Pharmaceutical. CAS No. 862507-23-1. Pack Sizes: 10 mg. Product ID: B0084-286454. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| LY-2456302 | LY-2456302, also called as CERC-501, is a potent, highly selective and centrally-penetrant kappa opioid receptor antagonist (Ki = 0.807 nM) with favorable pharmacokinetic and pharmacodynamic properties to evaluate the role of KOR in preclinical models of alcoholism. Group: Pharmaceutical. CAS No. 1174130-61-0. Pack Sizes: 100 mg. Product ID: B2693-007347. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| LY-2510924 | LY-2510924 is an inhibitor of CXC chemokine receptor 4 (CXCR4). It has potential antineoplastic activity. It binds to the chemokine receptor CXCR4, thereby preventing CXCR4 binding to its ligand, stromal derived factor-1 (SDF-1), and subsequent receptor activation upon subcutaneous administration, which may result in decreased tumor cell proliferation and migration. It plays an important role in chemotaxis and angiogenesis and is upregulated in several tumor cell types. Uses: Ly-2510924 has potential antineoplastic activity. it plays an important role in chemotaxis and angiogenesis. Group: Pharmaceutical. CAS No. 1088715-84-7. Pack Sizes: 5 mg. Product ID: BAT-006091. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| LY-2562175 | LY2562175 is a potent and selective FXR agonist in vitro. It has robust lipid modulating properties, lowering LDL and triglycerides while raising HDL in preclinical species. It was developed by Eli Lilly and Company and in clinic phase 1 trials with no progress. Uses: Ly2562175 has robust lipid modulating properties, lowering ldl and triglycerides while raising hdl in preclinical species. Group: Pharmaceutical. CAS No. 1103500-20-4. Pack Sizes: 10 mg. Product ID: B2693-475063. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
Would you like to list your products on UK Chemical Suppliers?
Our database is helping our users find suppliers everyday.